Kirkpatrick John P, Marks Lawrence B, Mayo Charles S, Lawrence Yaacov R, Bhandare Niranjan, Ryu Samuel
Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.
Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC, USA.
J Radiosurg SBRT. 2011;1(2):95-107.
Minimizing radiation-induced normal tissue damage in the central nervous system (CNS) is a key objective and primary impetus for stereotactic radiosurgery and radiotherapy. The recently published Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) study provides updated dose/volume/ outcome data on normal tissue tolerance for sixteen anatomic sites, including the CNS. Most of the data used to develop the relationship between dose, volume and normal tissue toxicity derived from large field, conventionally fractionated regimens, and quantitative dose/volume/outcome data at high doses per fraction to limited volumes is much sparser. Nonetheless, QUANTEC provides some limited recommendations for dose constraints in stereotactic radiosurgery/ radiotherapy of the CNS. This paper critically reviews the findings, recommendations and limitations of QUANTEC as they apply to radiosurgery of the CNS, as well as presenting suggestions to establish and validate clinically meaningful dose/volume/toxicity relationships in this setting.
将中枢神经系统(CNS)中辐射诱发的正常组织损伤降至最低,是立体定向放射外科和放射治疗的关键目标和主要推动力。最近发表的《临床正常组织效应定量分析》(QUANTEC)研究提供了包括中枢神经系统在内的16个解剖部位正常组织耐受性的最新剂量/体积/结果数据。用于建立剂量、体积与正常组织毒性之间关系的数据,大多来自大野常规分割方案,而关于高剂量单次分割至有限体积的定量剂量/体积/结果数据则要少得多。尽管如此,QUANTEC为中枢神经系统立体定向放射外科/放射治疗中的剂量限制提供了一些有限的建议。本文批判性地回顾了QUANTEC在适用于中枢神经系统放射外科方面的研究结果、建议和局限性,并提出了在此背景下建立和验证具有临床意义的剂量/体积/毒性关系的建议。